Aug. 8, 2013—Vanderbilt Heart and Vascular Institute is the first in the United States to use a new fully resorbable “envelope” that encloses implantable cardiac devices, such as pacemakers and internal cardioverter defibrillators (ICDs), and helps prevent surgical site infections.
Aug. 8, 2013—A new study of concussion in cheerleaders found neurocognitive testing was more accurate than an athlete’s symptom self-report when assessing recovery.
Aug. 5, 2013—Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week.
Aug. 1, 2013—Evolve to Excel (E2E), a comprehensive initiative designed to strengthen operational practices throughout Vanderbilt University Medical Center to ensure long-term success of the organization, is moving ahead.
Aug. 1, 2013—Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups.
Aug. 1, 2013—The Vanderbilt Program in Interprofessional Learning (VPIL) has received a $183,000 Baptist Healing Trust (BHT) grant to support team-based training called "Coaching for Compassionate Care: Developing a new model for health professions education.”